Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

CSF1R is required for differentiation and migration of Langerhans cells and Langerhans cell histiocytosis.

Lonardi S, Scutera S, Licini S, Lorenzi L, Cesinaro AM, Benerini Gatta L, Castagnoli C, Bollero D, Sparti R, Tomaselli M, Medicina D, Calzetti F, Cassatella MA, Facchetti F, Musso T, Vermi W.

Cancer Immunol Res. 2020 Apr 1. pii: canimm.0232.2019. doi: 10.1158/2326-6066.CIR-19-0232. [Epub ahead of print]

PMID:
32238382
2.

Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.

Monti M, Consoli F, Vescovi R, Bugatti M, Vermi W.

Cells. 2020 Feb 11;9(2). pii: E417. doi: 10.3390/cells9020417. Review.

3.

Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer.

Mandelli GE, Missale F, Bresciani D, Gatta LB, Scapini P, Caveggion E, Roca E, Bugatti M, Monti M, Cristinelli L, Belotti S, Simeone C, Calza S, Melocchi L, Vermi W.

Cells. 2020 Jan 25;9(2). pii: E291. doi: 10.3390/cells9020291.

4.

Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.

Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, Fosso B, Melocchi L, Nizzoli G, Troisi J, Marzano M, Oresta B, Spadoni I, Atarashi K, Carloni S, Arioli S, Fornasa G, Asnicar F, Segata N, Guglielmetti S, Honda K, Pesole G, Vermi W, Penna G, Rescigno M.

Nat Microbiol. 2020 Mar;5(3):511-524. doi: 10.1038/s41564-019-0649-5. Epub 2020 Jan 27.

PMID:
31988379
5.

The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, Bugatti M, Salvi V, Bernardini G, Benvenuti F, Vecchi A, Bottazzi B, Mantovani A, Sozzani S.

Cancer Immunol Res. 2019 Nov;7(11):1775-1788. doi: 10.1158/2326-6066.CIR-19-0168. Epub 2019 Sep 4.

PMID:
31484658
6.

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.

Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, Turati M, Taranto S, Zammataro L, Cerasuolo M, Bugatti M, Vermi W, Presta M, Ronca R.

Cancers (Basel). 2019 Aug 30;11(9). pii: E1277. doi: 10.3390/cancers11091277.

7.

Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.

Gatta LB, Melocchi L, Bugatti M, Missale F, Lonardi S, Zanetti B, Cristinelli L, Belotti S, Simeone C, Ronca R, Grillo E, Licini S, Bresciani D, Tardanico R, Chan SR, Giurisato E, Calza S, Vermi W.

Cancers (Basel). 2019 Aug 21;11(9). pii: E1219. doi: 10.3390/cancers11091219.

8.

The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.

Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, Doni A, Lonardi S, Astrid Boutet M, Nerviani A, Carriero R, Molgora M, Stravalaci M, Morone D, Shalova IN, Lee Y, Biswas SK, Mantovani G, Sironi M, Pitzalis C, Vermi W, Bottazzi B, Mantovani A, Locati M.

Nat Immunol. 2019 Aug;20(8):1012-1022. doi: 10.1038/s41590-019-0417-y. Epub 2019 Jul 1.

PMID:
31263276
9.

Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio.

Mattavelli D, Lombardi D, Missale F, Calza S, Battocchio S, Paderno A, Bozzola A, Bossi P, Vermi W, Piazza C, Nicolai P.

Front Oncol. 2019 Apr 30;9:339. doi: 10.3389/fonc.2019.00339. eCollection 2019.

10.

Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy.

Consoli F, Manganoni AM, Grisanti S, Petrelli F, Venturini M, Rangoni G, Guarneri F, Incardona P, Vermi W, Calzavara Pinton PG, Berruti A.

PLoS One. 2019 Apr 2;14(4):e0214884. doi: 10.1371/journal.pone.0214884. eCollection 2019.

11.

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.

Roca E, Pozzari M, Vermi W, Tovazzi V, Baggi A, Amoroso V, Nonnis D, Intagliata S, Berruti A.

Lung Cancer. 2019 Jan;127:12-18. doi: 10.1016/j.lungcan.2018.11.016. Epub 2018 Nov 13. Review.

PMID:
30642539
12.

Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2019 Jan;7(1):12-28. doi: 10.1158/2326-6066.CIR-18-0141. Epub 2018 Nov 6. Erratum in: Cancer Immunol Res. 2019 Apr;7(4):693.

13.

Pityriasis Lichenoides, Atypical Pityriasis Lichenoides, and Related Conditions: A Study of 66 Cases.

Borra T, Custrin A, Saggini A, Fink-Puches R, Cota C, Vermi W, Facchetti F, Cerroni L.

Am J Surg Pathol. 2018 Aug;42(8):1101-1112. doi: 10.1097/PAS.0000000000001093.

PMID:
29851705
14.

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Huergo-Zapico L, Parodi M, Cantoni C, Lavarello C, Fernández-Martínez JL, Petretto A, DeAndrés-Galiana EJ, Balsamo M, López-Soto A, Pietra G, Bugatti M, Munari E, Marconi M, Mingari MC, Vermi W, Moretta L, González S, Vitale M.

Cancer Res. 2018 Jul 15;78(14):3913-3925. doi: 10.1158/0008-5472.CAN-17-1891. Epub 2018 May 11.

15.

slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP.

Vermi W, Micheletti A, Finotti G, Tecchio C, Calzetti F, Costa S, Bugatti M, Calza S, Agostinelli C, Pileri S, Balzarini P, Tucci A, Rossi G, Furlani L, Todeschini G, Zamò A, Facchetti F, Lorenzi L, Lonardi S, Cassatella MA.

Cancer Res. 2018 Jul 1;78(13):3544-3559. doi: 10.1158/0008-5472.CAN-17-2344. Epub 2018 May 10.

16.

A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.

Tamassia N, Arruda-Silva F, Calzetti F, Lonardi S, Gasperini S, Gardiman E, Bianchetto-Aguilera F, Gatta LB, Girolomoni G, Mantovani A, Vermi W, Cassatella MA.

Front Immunol. 2018 Apr 17;9:795. doi: 10.3389/fimmu.2018.00795. eCollection 2018.

17.

Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.

Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, Finegan KG, Wang W, Wang J, Gray NS, Vermi W, Xia Z, Tournier C.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2801-E2810. doi: 10.1073/pnas.1707929115. Epub 2018 Mar 5.

18.

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, Cella M, Schmedt C, Colonna M.

Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.

19.

Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Costa ML, Robinette ML, Bugatti M, Longtine MS, Colvin BN, Lantelme E, Vermi W, Colonna M, Nelson DM, Cella M.

Front Immunol. 2017 Oct 25;8:1357. doi: 10.3389/fimmu.2017.01357. eCollection 2017.

20.

Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270.

Pagliari M, Munari F, Toffoletto M, Lonardi S, Chemello F, Codolo G, Millino C, Della Bella C, Pacchioni B, Vermi W, Fassan M, de Bernard M, Cagnin S.

Front Immunol. 2017 Oct 12;8:1288. doi: 10.3389/fimmu.2017.01288. eCollection 2017.

Supplemental Content

Loading ...
Support Center